Mission and Vision
Opioids have long been the default for chronic pain, despite their devastating consequences. At Alyea Therapeutics, our mission is clear: to end dependence on opioids by providing a safer, science-backed alternative.
With our investigational Low Dose Naltrexone (LDN), we are pioneering a new era in pain management for patients suffering from Complex Regional Pain Syndrome (CRPS)–one where lasting relief doesn’t come at the cost of addiction.
